InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Matinas BioPharma Holdings, Inc.

MTNB Clue Score45
United States Fiscal year ends December CIK 0001582554
$2.74 -4.53% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.74 +138.26% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.0Operating income−8.3Net income−7.6Fiscal year 2017Revenue0.1Operating income−16.5Net income−15.5Fiscal year 2018Revenue0.1 −20.0%Operating income−14.6Net income−14.1Fiscal year 2019Revenue0.1 −25.0%Operating income−18.9Net income−17.4Fiscal year 2020Revenue0.2 +76.3%Operating income−24.2Net income−22.4Fiscal year 2021Revenue0.0 −79.2%Operating income−24.7Net income−23.3Fiscal year 2022Revenue3.2 +9,560.6%Operating income−24.6Net income−21.0EPS, diluted−0.10Fiscal year 2023Revenue1.1 −65.6%Operating income−23.8Net income−22.9EPS, diluted−5.28Fiscal year 2024Operating income−24.6Net income−24.3EPS, diluted−4.98Fiscal year 2025Operating income−7.0Net income−10.3EPS, diluted−2.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 0.1 0.1 0.1 0.2 0.0 3.2 1.1 n/a n/a
Growth −20.0% −25.0% +76.3% −79.2% +9,560.6% −65.6%
Operating income −8.3 −16.5 −14.6 −18.9 −24.2 −24.7 −24.6 −23.8 −24.6 −7.0
Net income −7.6 −15.5 −14.1 −17.4 −22.4 −23.3 −21.0 −22.9 −24.3 −10.3
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a −0.10 −5.28 −4.98 −2.00

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Operating margin−11,024.6%Net margin−10,345.9%Free cash flow margin−8,285.2%Fiscal year 2018Operating margin−12,230.9%Net margin−11,760.4%Free cash flow margin−9,066.5%Fiscal year 2019Operating margin−21,067.4%Net margin−19,343.4%Free cash flow margin−16,142.2%Fiscal year 2020Operating margin−15,288.4%Net margin−14,177.0%Free cash flow margin−10,972.8%Fiscal year 2021Operating margin−74,954.5%Net margin−70,554.5%Free cash flow margin−46,918.2%Fiscal year 2022Operating margin−771.3%Net margin−658.6%Free cash flow margin−628.9%Fiscal year 2023Operating margin−2,168.4%Net margin−2,093.2%Free cash flow margin−1,413.9%Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −11,024.6% −12,230.9% −21,067.4% −15,288.4% −74,954.5% −771.3% −2,168.4% n/a n/a
Net margin n/a −10,345.9% −11,760.4% −19,343.4% −14,177.0% −70,554.5% −658.6% −2,093.2% n/a n/a
Free cash flow margin n/a −8,285.2% −9,066.5% −16,142.2% −10,972.8% −46,918.2% −628.9% −1,413.9% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−6.1Capital expenditure0.0Free cash flow−6.1Fiscal year 2017Operating cash flow−11.5Capital expenditure−0.9Free cash flow−12.4Fiscal year 2018Operating cash flow−10.3Capital expenditure−0.5Free cash flow−10.9Fiscal year 2019Operating cash flow−14.1Capital expenditure−0.4Free cash flow−14.5Fiscal year 2020Operating cash flow−17.4Capital expenditure−0.0Free cash flow−17.4Fiscal year 2021Operating cash flow−15.2Capital expenditure−0.3Free cash flow−15.5Fiscal year 2022Operating cash flow−19.2Capital expenditure−0.9Free cash flow−20.0Fiscal year 2023Operating cash flow−15.3Capital expenditure−0.2Free cash flow−15.5Fiscal year 2024Operating cash flow−15.9Fiscal year 2025Operating cash flow−7.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −6.1 −11.5 −10.3 −14.1 −17.4 −15.2 −19.2 −15.3 −15.9 −7.0
Capital expenditure 0.0 −0.9 −0.5 −0.4 −0.0 −0.3 −0.9 −0.2 n/a n/a
Free cash flow −6.1 −12.4 −10.9 −14.5 −17.4 −15.5 −20.0 −15.5 n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash4.1Shareholders’ equity7.1Fiscal year 2017Cash7.3Shareholders’ equity10.7Fiscal year 2018Cash12.4Shareholders’ equity16.1Fiscal year 2019Cash22.2Shareholders’ equity33.1Fiscal year 2020Cash12.4Shareholders’ equity63.7Fiscal year 2021Cash21.0Shareholders’ equity52.5Fiscal year 2022Cash6.8Shareholders’ equity36.6Fiscal year 2023Cash4.8Shareholders’ equity19.2Fiscal year 2024Cash7.3Shareholders’ equity7.6Fiscal year 2025Cash4.0Shareholders’ equity4.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 4.1 7.3 12.4 22.2 12.4 21.0 6.8 4.8 7.3 4.0
Shareholders’ equity 7.1 10.7 16.1 33.1 63.7 52.5 36.6 19.2 7.6 4.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a −11,024.6% −12,230.9% −21,067.4% −15,288.4% −74,954.5% −771.3% −2,168.4% n/a n/a
n/a n/a n/a n/a n/a n/a n/a −2,093.2% n/a n/a
n/a −10,345.9% −11,760.4% −19,343.4% −14,177.0% −70,554.5% −658.6% −2,093.2% n/a n/a
n/a −8,285.2% −9,066.5% −16,142.2% −10,972.8% −46,918.2% −628.9% −1,413.9% n/a n/a
Spending
n/a 6,019.6% 5,668.0% 12,509.0% 9,068.8% 44,190.9% 523.1% 1,322.0% n/a n/a
n/a 5,105.0% 6,662.9% 8,658.4% 6,319.6% 30,863.6% 348.2% 946.4% n/a n/a
n/a 629.4% 447.5% 451.6% 3.6% 787.9% 28.0% 19.9% n/a n/a
Returns
−106.3% −145.0% −87.2% −52.6% −35.2% −44.4% −57.3% −119.2% −319.5% −214.2%
−77.4% −107.4% −70.6% −43.2% −31.6% −38.0% −46.8% −91.4% −191.8% −143.5%
Balance and payout
27.2% 25.9% 19.1% 17.9% 10.2% 14.4% 18.3% 23.3% 40.0% 33.0%